Device / Technology News

RSS

Mount Sinai team wins million dollar prize for the development of Biomni-AD

Mount Sinai team wins million dollar prize for the development of Biomni-AD

A team led by Dr. Kuan-lin Huang, PhD, has been named a winner of the $1 million Alzheimer's Insights AI Prize, the Alzheimer's Disease Data Initiative (AD Data Initiative) announced on March 20. Dr. Huang is an Associate Professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai.

27 Mar 2026

New AI tool assesses the potential threat posed by new bacteria

New AI tool assesses the potential threat posed by new bacteria

Researchers have developed an AI tool that can help determine whether unfamiliar bacteria carry genetic features linked to disease.

27 Mar 2026

Machine learning model can predict 28-day mortality in sepsis patients

Machine learning model can predict 28-day mortality in sepsis patients

Sepsis is one of the most common and lethal syndromes encountered in intensive care units (ICUs), and acute respiratory failure (ARF) represents one of its most critical complications.

27 Mar 2026

Video modeling interventions enhance romantic relationship skills in young adults with IDD

Video modeling interventions enhance romantic relationship skills in young adults with IDD

For too long, individuals with intellectual and developmental disabilities (IDD) have been denied the same opportunities for love, romance and sexual expression as their peers.

27 Mar 2026

New tool identifies harmful nutrition misinformation and evaluates potential risk

New tool identifies harmful nutrition misinformation and evaluates potential risk

A new tool that not only identifies diet and nutrition misinformation online but also evaluates the content's risk for potential harm has been developed by a team of UCL researchers.

27 Mar 2026

Liposomal nanotechnology enhances precision and efficacy in photodynamic cancer therapy

Liposomal nanotechnology enhances precision and efficacy in photodynamic cancer therapy

Photodynamic therapy (PDT) uses light to activate special drugs called photosensitizers to destroy cancer cells with high precision.

27 Mar 2026

Machine learning model predicts liver cancer risk with high accuracy

Machine learning model predicts liver cancer risk with high accuracy

A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common type of liver cancer, with high accuracy.

26 Mar 2026

Microfluidic chips enable realistic modeling of tumor immune environments

Microfluidic chips enable realistic modeling of tumor immune environments

The challenge is that the tumor immune microenvironment is not a static backdrop but a constantly shifting ecosystem shaped by cancer cells, immune cells, stromal cells, cytokines, and physical barriers.

26 Mar 2026

New algorithm enables precise subtyping of metabolic liver disease

New algorithm enables precise subtyping of metabolic liver disease

Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes affecting more than 30% individuals globally.

26 Mar 2026

The new Nexera IC ion chromatograph - Reliable water quality analysis and reduced workload through smooth operation

The new Nexera IC ion chromatograph - Reliable water quality analysis and reduced workload through smooth operation

Shimadzu, a leading global supplier of analytical measurement and testing equipment, has recently released the Nexera IC ion chromatograph.

From Shimadzu Europa GmbH 26 Mar 2026

The new microchip electrophoresis system MultiNA II MCE-301- High sensitivity detection, improved analysis function and operability

The new microchip electrophoresis system MultiNA II MCE-301- High sensitivity detection, improved analysis function and operability

Shimadzu has recently released the MultiNA II MCE-301 microchip electrophoresis system. By automating the entire process of electrophoresis, which takes more than two hours by hand (creation of gels, dispensing reagents, dispensing sample, separation, dyeing, cleaning of equipment), the company significantly improves the efficiency of genetic analysis operations.

From Shimadzu Europa GmbH 26 Mar 2026

Nexis GC-2060: The culmination of 70 years of GC development

Nexis GC-2060: The culmination of 70 years of GC development

To celebrate the 70th birthday of its gas chromatography (GC) product line, Shimadzu announces the release of the Nexis GC-2060 gas chromatograph, the flagship model in its GC lineup.

From Shimadzu Europa GmbH 26 Mar 2026

GC product division celebrates 70th anniversary, European and world premieres underscore progress in laboratory analytics

GC product division celebrates 70th anniversary, European and world premieres underscore progress in laboratory analytics

Today, analytica opens its doors in Munich from March 24th to 27th. Shimadzu, a global supplier of analytical measurement and testing equipment, is once again present at the world's leading trade fair – and delighted to be celebrating another anniversary so soon after its 150th birthday last year: the 70th anniversary of its gas chromatography (GC) product line.

From Shimadzu Europa GmbH 26 Mar 2026

Shimadzu’s design craftech - Fusing traditional Kyoto craft techniques with industrial production

Shimadzu’s design craftech - Fusing traditional Kyoto craft techniques with industrial production

Shimadzu Corporation, which was celebrating its 150th anniversary in 2025, has a long history of involvement with traditional Kyoto crafts dating back to its origins as a maker of Buddhist altar fittings.

From Shimadzu Europa GmbH 26 Mar 2026

Can AI chatbots help brain tumor patients understand their care?

Can AI chatbots help brain tumor patients understand their care?

Integrating LLMs in brain tumor care could enhance patient understanding, but requires strict oversight to manage risks and ensure reliable information.

26 Mar 2026

Championing innovation: Bedfont® Scientific CTO shortlisted for Technology Leader of the Year

Championing innovation: Bedfont® Scientific CTO shortlisted for Technology Leader of the Year

Scott Deamer-Smith, Chief Technology Officer (CTO) at Bedfont® Scientific Limited, has been recognized for his outstanding contribution to innovation and technology.

From Bedfont® Scientific Ltd 26 Mar 2026

Spear Bio introduces new ultra-sensitive neurodegenerative assays and expands direct access at AD/PD 2026

Spear Bio introduces new ultra-sensitive neurodegenerative assays and expands direct access at AD/PD 2026

Spear Bio, an innovator in ultrasensitive protein biomarker detection, showcased three new SPEAR UltraDetect™ immunoassays—brain-derived p-Tau 217 (BD-pTau 217), α-synuclein (α-syn) and phospho-Ser129-α-synuclein (pS129-α-syn)—at the International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD 2026) last week.

From Spear Bio 26 Mar 2026

Study finds AI-generated X-rays can fool radiologists and chatbots

Study finds AI-generated X-rays can fool radiologists and chatbots

Researchers found that both radiologists and multimodal AI models had only moderate success distinguishing synthetic radiographs from real clinical images, even when told fakes were present. The study warns that increasingly realistic AI-generated X-rays could be misused in medicine, research, insurance, and litigation, strengthening the case for watermarking, clinician training, and dedicated detection tools.

25 Mar 2026

MIT engineers design ultrasound wristband to track complex hand movements

MIT engineers design ultrasound wristband to track complex hand movements

The next time you're scrolling your phone, take a moment to appreciate the feat: The seemingly mundane act is possible thanks to the coordination of 34 muscles, 27 joints, and over 100 tendons and ligaments in your hand.

25 Mar 2026

Optibrium introduces graphical interface for QuanSA to enhance ligand-based affinity predictions

Optibrium introduces graphical interface for QuanSA to enhance ligand-based affinity predictions

Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA™ plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of the Company's BioPharmics 3D molecular modelling platform.

From Optibrium Ltd. 25 Mar 2026

1
2
3
4
...
2425
Next

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.